Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for ELF3_EHF
Z-value: 1.35
Motif logo
Transcription factors associated with ELF3_EHF
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ELF3
|
ENSG00000163435.11 | E74 like ETS transcription factor 3 |
|
EHF
|
ENSG00000135373.8 | ETS homologous factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ELF3 | hg19_v2_chr1_+_201979645_201979721 | 0.30 | 7.9e-06 | Click! |
| EHF | hg19_v2_chr11_+_34642656_34642682 | 0.13 | 6.0e-02 | Click! |
Activity profile of ELF3_EHF motif
Sorted Z-values of ELF3_EHF motif
Network of associatons between targets according to the STRING database.
First level regulatory network of ELF3_EHF
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.5 | 32.5 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 6.3 | 18.9 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
| 5.1 | 15.4 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 4.4 | 13.2 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 4.1 | 8.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
| 4.0 | 55.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 3.5 | 13.9 | GO:0019086 | late viral transcription(GO:0019086) |
| 3.5 | 10.4 | GO:0072716 | response to actinomycin D(GO:0072716) |
| 3.4 | 13.8 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 3.3 | 6.7 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) regulation of actin nucleation(GO:0051125) |
| 3.2 | 12.9 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 3.1 | 3.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 2.9 | 5.8 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 2.8 | 8.5 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) regulation of progesterone biosynthetic process(GO:2000182) |
| 2.7 | 8.1 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 2.6 | 7.8 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 2.5 | 7.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 2.4 | 7.3 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 2.4 | 7.3 | GO:1901899 | dense core granule biogenesis(GO:0061110) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
| 2.3 | 11.6 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 2.3 | 30.0 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 2.2 | 24.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 2.1 | 12.6 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 2.1 | 8.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 2.0 | 16.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 2.0 | 21.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 2.0 | 6.0 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 2.0 | 19.8 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 1.9 | 15.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.9 | 14.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 1.8 | 5.5 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 1.8 | 5.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 1.8 | 5.4 | GO:0018282 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 1.8 | 35.7 | GO:0031167 | rRNA methylation(GO:0031167) |
| 1.8 | 10.6 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 1.7 | 5.1 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 1.7 | 5.1 | GO:0032887 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 1.7 | 9.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 1.6 | 4.9 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
| 1.6 | 4.9 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 1.6 | 30.2 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 1.6 | 6.3 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 1.6 | 4.7 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 1.6 | 4.7 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 1.6 | 9.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 1.5 | 4.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 1.5 | 9.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 1.5 | 6.1 | GO:0001743 | optic placode formation(GO:0001743) |
| 1.5 | 4.5 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
| 1.4 | 10.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 1.4 | 7.1 | GO:2000843 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 1.4 | 2.8 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 1.4 | 23.6 | GO:0006265 | DNA topological change(GO:0006265) |
| 1.4 | 8.3 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 1.4 | 5.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 1.4 | 4.1 | GO:0070781 | response to biotin(GO:0070781) |
| 1.4 | 6.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 1.3 | 8.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 1.3 | 3.9 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 1.3 | 15.2 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 1.3 | 3.8 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 1.3 | 3.8 | GO:0021836 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
| 1.3 | 3.8 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 1.2 | 5.0 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 1.2 | 5.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 1.2 | 6.2 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 1.2 | 3.7 | GO:1900244 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 1.2 | 7.1 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 1.2 | 5.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) minus-end-directed organelle transport along microtubule(GO:0072385) |
| 1.1 | 6.9 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 1.1 | 3.3 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 1.1 | 3.2 | GO:0061055 | myotome development(GO:0061055) |
| 1.0 | 6.3 | GO:0033504 | floor plate development(GO:0033504) |
| 1.0 | 13.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 1.0 | 3.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
| 1.0 | 4.0 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 1.0 | 25.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 1.0 | 23.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 1.0 | 8.9 | GO:0006531 | aspartate metabolic process(GO:0006531) |
| 1.0 | 4.9 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
| 1.0 | 1.9 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 1.0 | 4.8 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 1.0 | 4.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 1.0 | 2.9 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.9 | 3.7 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.9 | 5.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.9 | 2.6 | GO:2000097 | chronological cell aging(GO:0001300) regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.9 | 2.6 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.9 | 9.5 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.9 | 2.6 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.9 | 3.4 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
| 0.9 | 11.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.8 | 13.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.8 | 9.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.8 | 9.9 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.8 | 4.7 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 0.8 | 11.0 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.8 | 8.7 | GO:0015886 | heme transport(GO:0015886) |
| 0.8 | 4.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.8 | 12.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.8 | 6.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.8 | 11.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.8 | 2.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.8 | 4.5 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.7 | 2.2 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.7 | 5.2 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.7 | 4.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.7 | 0.7 | GO:0065001 | specification of axis polarity(GO:0065001) |
| 0.7 | 7.8 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.7 | 2.1 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
| 0.7 | 3.6 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.7 | 2.8 | GO:0042335 | cuticle development(GO:0042335) |
| 0.7 | 5.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.7 | 4.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.7 | 3.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.7 | 4.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) secretory granule localization(GO:0032252) |
| 0.7 | 2.1 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
| 0.7 | 32.8 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
| 0.7 | 17.0 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.7 | 3.4 | GO:0030047 | actin modification(GO:0030047) |
| 0.7 | 2.0 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.7 | 5.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.7 | 2.7 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.7 | 3.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.7 | 2.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.7 | 2.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.7 | 15.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.6 | 3.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.6 | 4.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.6 | 1.9 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.6 | 6.9 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.6 | 4.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.6 | 17.3 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.6 | 1.2 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.6 | 3.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.6 | 1.8 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 0.6 | 3.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.6 | 4.1 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.6 | 10.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.6 | 5.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.6 | 1.7 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.6 | 4.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.6 | 1.7 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.6 | 12.4 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.6 | 3.9 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.6 | 1.7 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 0.5 | 15.8 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.5 | 1.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.5 | 2.2 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 0.5 | 2.1 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.5 | 2.1 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.5 | 4.2 | GO:0015705 | iodide transport(GO:0015705) |
| 0.5 | 1.5 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 0.5 | 3.6 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
| 0.5 | 12.7 | GO:0032607 | interferon-alpha production(GO:0032607) |
| 0.5 | 1.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.5 | 1.0 | GO:0003249 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
| 0.5 | 2.9 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.5 | 7.3 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.5 | 0.5 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.5 | 1.9 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
| 0.5 | 1.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.5 | 6.7 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
| 0.5 | 1.4 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.5 | 2.8 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.5 | 3.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.5 | 1.9 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.5 | 3.2 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.5 | 5.0 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.4 | 1.3 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
| 0.4 | 3.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.4 | 2.6 | GO:0060011 | sperm ejaculation(GO:0042713) Sertoli cell proliferation(GO:0060011) |
| 0.4 | 9.8 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.4 | 1.7 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
| 0.4 | 2.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.4 | 1.3 | GO:0009078 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.4 | 15.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.4 | 2.5 | GO:0006561 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
| 0.4 | 16.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.4 | 4.6 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.4 | 2.9 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.4 | 2.0 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.4 | 2.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.4 | 4.9 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.4 | 1.2 | GO:1902309 | regulation of heart rate by hormone(GO:0003064) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.4 | 5.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.4 | 2.0 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.4 | 6.8 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.4 | 5.9 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.4 | 0.8 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.4 | 6.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.4 | 3.1 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.4 | 1.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 0.4 | 1.9 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.4 | 2.6 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.4 | 5.9 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.4 | 2.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.4 | 1.1 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.4 | 8.5 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.4 | 13.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.4 | 2.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.3 | 2.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
| 0.3 | 2.8 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.3 | 5.8 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.3 | 4.8 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.3 | 5.4 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.3 | 3.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.3 | 4.3 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.3 | 2.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.3 | 1.9 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.3 | 4.1 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.3 | 10.1 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.3 | 4.4 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.3 | 3.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.3 | 6.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.3 | 0.6 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
| 0.3 | 2.1 | GO:0071158 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) positive regulation of cell cycle arrest(GO:0071158) |
| 0.3 | 13.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.3 | 14.2 | GO:0007050 | cell cycle arrest(GO:0007050) |
| 0.3 | 2.1 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.3 | 2.9 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.3 | 0.9 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.3 | 6.9 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.3 | 1.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.3 | 1.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.3 | 1.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.3 | 2.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.3 | 2.7 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
| 0.3 | 3.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.3 | 3.2 | GO:0035878 | nail development(GO:0035878) |
| 0.3 | 0.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.3 | 4.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.3 | 20.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.3 | 3.2 | GO:0046051 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
| 0.3 | 2.3 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.3 | 3.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.3 | 12.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.3 | 0.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.3 | 9.9 | GO:0042073 | intraciliary transport(GO:0042073) |
| 0.3 | 1.3 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.3 |